Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Cerevel Therapeutics is a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric disorders.
Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.
Zentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.
GeneDx uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.
Targeting pathways that modify RNA to deliver novel cancer therapeutics
Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.
Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat diseases
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Anaveon is a developing IL-2 complexes which selectively promote effector T cell functions.
Kestrel Therapeutics is a medical research and devenlopment company that offers treatment solutions for RAS cancers.
Anjarium is focused on creating new class of non-viral gene therapies to deliver predictable ,inclusionary ways to tackle genetic diseases.
Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.
Montis Biosciences is develops novel immune-oncology therapeutics targeting the intersection between vascular dysfunction.
Developing disease specific immune therapies to treat severe, chronic auto-immune, inflammatory, allergic, infectious diseases and tumors.
LianBio aims to develop and accelerate availability of paradigm-shifting medicines to patients in China.
Palleon Pharmaceuticals is a developer of a biotechnology platform designed to offer glycoimmune checkpoint inhibitors to treat cancer.
Metabomed designs drugs that treats cancer.
Triplet is developing transformative therapies that treat repeat expansion disorders at their source.
Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.
M-Tiba is a wallet platform that allows users to save and accrue funds for any future or ongoing medical emergency.
Mitokinin is operates in the healthcare industry focusing on biotechnology business.
NeuMoDx Molecular, Inc. operates as a molecular diagnostics company. The company develops solutions for molecular diagnostic (MDx) testing
Cydan is an orphan drug accelerator focused on identifying and de-risking compounds with therapeutic and commercial potential.
Autifony Therapeutics is a biotechnology company developing medicines to treat hearing disorders such as hearing loss and tinnitus.
Pfizer has invested in 100 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Pfizer's top investment sectors include Biotechnology, Health Care, Therapeutics, Pharmaceutical, Medical. The firm invests across 17 different industry categories.
Among tracked funding rounds, Cerevel Therapeutics received $450.0M in a Post Ipo Equity round. Pfizer's total known invested capital is $4.0B.
Pfizer's average investment size is $92.6M across its portfolio of 100 companies.
Recent Pfizer portfolio additions include Cerevel Therapeutics, Caribou Biosciences, Zentalis Pharmaceuticals, GeneDx, Storm Therapeutics. These companies were founded in 2020 or later.